Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Plegridy (Peginterferon beta-1a) (BIIB017)
print preview
bookmark
share with colleague
General Information
Company
Biogen Idec Inc.
Description
Pegylated interferon (IFN) beta-1a
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase III
Indication
Multiple sclerosis (MS)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy